| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-06 |